Identification of Medication Adherence Barriers intervention

The Identification of Medication Adherence Barriers Questionnaire intervention (IMAB-Qi) research programme is a one year programme to develop a trial to evaluate the effectiveness and cost-effectiveness of a primary care medication adherence intervention. 

Development of the IMAB-Q

The intervention in the IMAB-Qi study will involve using the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) to support practitioners and patients to work together to address medication non-adherence. 

The IMAB-Q was developed through a review of the literature, mapping individual barriers to the Theoretical Domains Framework and focus groups with people prescribed medication to get a better understanding of the barriers to medication adherence.   

Discover how the IMAB-Q was developed and validated.

The IMAB-Qi research programme

The IMAB-Qi programme comprises three phases:

1. Convening a Primary Care Influencer Group

2. Developing a Core Outcome Set for medication adherence trials

• Study protocol

Information for patients and carers:

• Invitation letter for patients and carers (PDF, 112kb)
• Information sheet for patients and carers (PDF, 229kb)

Information for practice teams and academics:

• Information sheet for practice teams and academics (PDF, 243kb)

3. Discover how the IMAB-Qi is being operationalised